Hypertrophic Cardiomyopathy - Pipeline Review, H2 2016
"Hypertrophic Cardiomyopathy - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Pipeline Review, H2 2016, provides an overview of the Hypertrophic Cardiomyopathy (Cardiovascular) pipeline landscape. Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it harder for the heart to pump blood. Symptoms include chest pain, especially during exercise, sensation of rapid, fluttering or pounding heartbeats and heart murmur. Hypertrophic cardiomyopathy usually is inherited. Treatment includes beta blockers, calcium channel blockers and blood thinners. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=